Therapeutics Company Announces U.S. Patent For Heart Therapy Treatment
BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach.
Disclaimer: The information provided in this article is based on a press release from BioCardia, Inc. It includes details about a recent patent issuance and should not be considered as medical advice. Readers are encouraged to consult with healthcare professionals for medical concerns.
As an investor it's important to stay updated…